EUVIMEDEUVIMED entdecken
Crossref

Structure-Guided Discovery of Orally Bioavailable Allosteric SLC6A19 Inhibitors that Promote Urinary Amino Acid Excretion In Vivo

Tao Wang iD, Matthew S Dowling iD, Dahui Zhou iD, David Jonathan Wasilko, Meihua Tu, Denis Feliers, Barbara Bernardo, Joseph Tillotson, Wenzhe Ma, Janice Brown, Zachary Johnson iD, Joshua A Lees und 41 weitere

Journal of Medicinal Chemistry · 12.11.2026 · 69 (21) · 26102-26115

DOI: 10.1021/acs.jmedchem.6c02154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 14.10.2026. Verfasst von Tao Wang und 52 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Research & Development , 1 Portland St, Cambridge, Massachusetts02139, United States. Hauptthemen laut MEDLINE: Amino Acids, Amino Acid Transport Systems, Neutral, Amino Acid Transport Systems. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SLC6A19 is a sodium-dependent transporter that mediates the absorption of neutral amino acids in the intestine and reabsorption of these amino acids in the kidney. Pharmacological inhibition of SLC6A19 may provide therapeutic benefit by normalizing plasma amino acid levels and potentially reducing renal tubular transport burden. Virtual screening against an allosteric binding pocket observed in the cryo-EM structure of SLC6A19/cinromide (1) identified compound 6 as a promising hit. The cryo-EM structure of SLC6A19/CB3 (2) revealed a second, partially overlapping pocket adjacent to the compound 6 binding site. Analogue design merging these two binding pockets followed by optimization led to compound 20, a potent, selective, and orally bioavailable allosteric SLC6A19 inhibitor. While compound 20 demonstrates an approximately 10-fold rightward potency shift against mouse SLC6A19, it retains good potency against non-human primate SLC6A19. Consistent with the SLC6A19 inhibition mechanism, oral dosing of 20 led to increased urinary amino acid excretion in a dose-dependent manner in human SLC6A19 knock-in mice and wild-type non-human primates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino AcidsAmino Acid Transport Systems, NeutralAmino Acid Transport SystemsAnimalsHumansAdministration, OralMiceAllosteric RegulationStructure-Activity RelationshipBiological AvailabilityDrug DiscoveryModels, MolecularMaleBinding SitesCryoelectron Microscopy

Stichwörter der Autor:innen

SLC6A19allosteric inhibitoramino acidskidney

Substanzen

Amino AcidsSLC6A19 protein, humanSLC6A19 protein, mouseAmino Acid Transport Systems, NeutralAmino Acid Transport Systems

Autor:innen und Institutionen

  • Pfizer Research & Development , 1 Portland St, Cambridge, Massachusetts02139, United States.
  • Pfizer Research & Development, 445 Eastern Point Rd, Groton, Connecticut06340, United States.

ORCID-Profile: Tao Wang, Matthew S Dowling, Dahui Zhou, Zachary Johnson, Andrew Fensome, Caroline A Blakemore, Jamison B Tuttle, John Murray, Jun Xiao, Kevin D Hesp, Emily Jordan, Amit S Kalgutkar, Amy Moody, Huixian Wu, Matthew F Sammons, Lei Zhang, Yuan Zhang

Zitieren

APA

Wang, T., Dowling, M. S., Zhou, D., Wasilko, D. J., Tu, M., Feliers, D., Bernardo, B., Tillotson, J., Ma, W., Brown, J., Johnson, Z., Lees, J. A., Fensome, A., Shavnya, A., Clemens, J., Coffey, S., Blakemore, C. A., Avery, M., Tuttle, J. B., …, & Zhang, Y. (2026). Structure-Guided Discovery of Orally Bioavailable Allosteric SLC6A19 Inhibitors that Promote Urinary Amino Acid Excretion In Vivo. Journal of Medicinal Chemistry, 69(21), 26102-26115. https://doi.org/10.1021/acs.jmedchem.6c02154

Vancouver

Wang T, Dowling MS, Zhou D, Wasilko DJ, Tu M, Feliers D, et al. Structure-Guided Discovery of Orally Bioavailable Allosteric SLC6A19 Inhibitors that Promote Urinary Amino Acid Excretion In Vivo. Journal of Medicinal Chemistry. 2026;69(21):26102-26115. doi:10.1021/acs.jmedchem.6c02154

BibTeX
@article{Wang2026,
  author = {Wang, Tao and Dowling, Matthew S and Zhou, Dahui and Wasilko, David Jonathan and Tu, Meihua and Feliers, Denis and Bernardo, Barbara and Tillotson, Joseph and Ma, Wenzhe and Brown, Janice and Johnson, Zachary and Lees, Joshua A and Fensome, Andrew and Shavnya, Andre and Clemens, Jennifer and Coffey, Steven and Blakemore, Caroline A and Avery, Melissa and Tuttle, Jamison B and Hudson, Phillip and Korczynska, Magdalena and Murray, John and Williams, Jade and Xiao, Jun and Dutra, Jason and Hernandez, Dianne and Hesp, Kevin D and Mascitti, Vincent and Jagarlapudi, Srinath and Keenan, Rose and Ward, Jessica and Barnes, Robert and Jordan, Emily and Ochocki, Natalie and Callahan, Daniel and Steen, Kimberly and Kalgutkar, Amit S and Fonseca, Kari R and Sharma, Raman and Ferguson, Nicholas and King-Ahmad, Amanda and Bessire, Andrew J and Moody, Amy and Maurer, Tristan S and Stock, Ingrid A and Sommese, Ruth and Phillips, Tracy and Loria, Paula M and Wu, Huixian and Hepworth, David and Sammons, Matthew F and Zhang, Lei and Zhang, Yuan},
  title = {Structure-Guided Discovery of Orally Bioavailable Allosteric SLC6A19 Inhibitors that Promote Urinary Amino Acid Excretion In Vivo},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {21},
  pages = {26102--26115},
  doi = {10.1021/acs.jmedchem.6c02154}
}
Kostenlos starten →